345 related articles for article (PubMed ID: 8573897)
1. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
[No Abstract] [Full Text] [Related]
2. The link between dialysate and chronic inflammatory disease in hemodialysis.
Amato RL
Nephrol Nurs J; 2002 Oct; 29(5):490-2. PubMed ID: 12434456
[No Abstract] [Full Text] [Related]
3. Importance of endotoxins in high-flux dialysis.
Smollich BP; Falkenhagen D; Schneidewind J; Mitzner S; Klinkmann H
Nephrol Dial Transplant; 1991; 6 Suppl 3():83-5. PubMed ID: 1775273
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis.
Karacan O; Tutal E; Colak T; Sezer S; Eyüboğlu FO; Haberal M
Transplant Proc; 2006 Mar; 38(2):396-400. PubMed ID: 16549130
[TBL] [Abstract][Full Text] [Related]
5. [Adhesion molecules in patients with chronic renal failure treated with haemodialysis].
Musiał K; Zwolińska D
Pol Merkur Lekarski; 2002 Sep; 13(75):177-81. PubMed ID: 12474564
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers.
Griveas I; Visvardis G; Sakellariou G; Passadakis P; Thodis I; Vargemezis V; Pavlitou A; Fleva A
Ren Fail; 2006; 28(6):493-9. PubMed ID: 16928619
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
MacLeod A; Grant A; Donaldson C; Khan I; Campbell M; Daly C; Lawrence P; Wallace S; Vale L; Cody J; Fitzhugh K; Montague G; Ritchie C
Health Technol Assess; 1998; 2(5):1-166. PubMed ID: 9621129
[No Abstract] [Full Text] [Related]
8. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
Lonnemann G; Schindler R
Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
[No Abstract] [Full Text] [Related]
9. Side effects due to materials used in hemodialysis equipment.
Bommer J; Ritz E; Andrassy K
Adv Nephrol Necker Hosp; 1985; 14():409-38. PubMed ID: 3919542
[No Abstract] [Full Text] [Related]
10. Dialysis membrane biocompatibility: effects on cellular elements.
Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
[No Abstract] [Full Text] [Related]
11. Problems and solutions for artificial kidney.
Vanholder R
Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
[TBL] [Abstract][Full Text] [Related]
12. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
13. Long-term experience with high-flux polysulfone in hemodialysis.
Civati G; Teatini U; Guastoni C; Perego A; Perrino ML; Ballerini L; Minetti L
Clin Nephrol; 1994 Jul; 42 Suppl 1():S26-30. PubMed ID: 7923979
[No Abstract] [Full Text] [Related]
14. [Blood purification and endotoxin].
Suzue N; Minakuti J
Nihon Rinsho; 2004 May; 62 Suppl 5():223-6. PubMed ID: 15197919
[No Abstract] [Full Text] [Related]
15. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
[TBL] [Abstract][Full Text] [Related]
17. Advances and innovations in dialysis in the 21st century.
Power A; Duncan N; Goodlad C
Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis using high flux membranes improves lipid profiles.
Blankestijn PJ
Clin Nephrol; 1994 Jul; 42 Suppl 1():S48-51. PubMed ID: 7923984
[No Abstract] [Full Text] [Related]
20. Biocompatible membranes and hemodynamic tolerance to hemodialysis.
Branger B; Deschodt G; Oules R; Balducchi JP; Granolleras C; Alsabadani B; Fourcade J; Shaldon S
Kidney Int Suppl; 1988 Mar; 24():S196-7. PubMed ID: 3163048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
